Pharmafile Logo
Pharmafocus logo
Advanced Search
European Parliament

EMA tightens conflict of interest rules

October 6, 2011
Research and Development, Sales and Marketing EMA

The European Medicines Agency is tightening up its conflict of interest rules with a new ‘experts database’. This will allow …

News

Merck appoints new chief strategy officer

October 6, 2011
Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, research and development, sales and marketing

Cuong Viet Do has joined Merck & Co as chief strategy officer, replacing Mervyn Turner who retired from the US …

Appointment

Call for open access to all clinical trial data

October 6, 2011
Research and Development Cochrane, clinical trials, clinical trials analysis

There should be free access to all clinical trials in order to end selective reporting, according to a leading not-for-profit …

News
Merck Serono

Merck KGaA signs MS and cancer research deal

October 5, 2011
Research and Development Merck KGaA

Merck KGaA has signed development deals with Japanese firm Ono Pharmaceutical Co around two investigational treatments, one for multiple sclerosis …

News
NICE headquarters

NICE to review wider use of off-label prescribing

October 5, 2011
Sales and Marketing off label, off label prescribing

The government has asked NICE to review its plans to give doctors greater freedom for ‘off-label’ prescribing. It wants NICE, …

News

Blocking pain – a long-term mission for pharma research

October 5, 2011
Research and Development chronic pain, neuropathic pain, pain therapeutics

Pain is a common, yet complex, clinical problem and one which remains an area of unmet need. There are however, …

Feature
sm

Steve Mott joins DrugLogic

October 5, 2011
Research and Development appointment, outcomes research, personalised medicine, pharmacovigilance, research and development

Former Datapharm Communications chief executive Steve Mott has been apppointed UK managing director by DrugLogic.The US firm develops analytical tools …

Appointment

Contract research news in brief

October 5, 2011
Research and Development research and development news

Clinipace raises $15m, PPD appoints a new chief executive and there are updates from Quintiles, PharmaNet and DaVita Clinical Research. …

News

Health reforms will do ‘irreparable’ damage to public health

October 4, 2011
NHS reforms

Doctors have urged the House of Lords to reject the Health and Social Care Bill, saying the proposed legislation will …

News
adaptimmune_helen_tm1

Adaptimmune makes board appointments

October 4, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

UK and US-based cell therapy company Adaptimmune has made two new appointments to its board. Dr Jonathan Knowles joins as …

Appointment
Roche Nutley

Manufacturing makes a comeback at Roche’s Nutley site

October 4, 2011
Manufacturing and Production Roche, pharma manufacturing news

Roche has opened a new manufacturing facility at its campus in Nutley, New Jersey, that will supply dosage forms for …

News

Merck pays $1.5m penalty for US pollution

October 4, 2011
Manufacturing and Production Merck & Co, pharma manufacturing news

Merck & Co has fallen foul of US regulations on environmental controls at two manufacturing plants and agreed to pay …

News

Digital Pharma: NHS-backed health social network launches

October 3, 2011
Medical Communications Digital Pharma blog, NHS, social media

A new NHS-backed social network has launched to provide support to patients with long-term conditions through ‘personal health planning’. How …

News

Pharma manufacturing news in brief

October 3, 2011
Manufacturing and Production pharma manufacturing news

Our round-up of pharma manufacturing news sees a green energy drive from GSK, facility updates from Stirling Pharma, Reckitt Benckiser …

News
Takeda

Takeda completes Nycomed acquisition, installs new chief executive

October 3, 2011
Sales and Marketing Nycomed, Takeda

Takeda Pharmaceutical Company has completed its acquisition of Nycomed and named Frank Morich as chief executive of the Zurich-based firm. …

News

Trial disappointment for AZ lung cancer drug

October 3, 2011
Research and Development, Sales and Marketing AstraZeneca, selumetinib

AstraZeneca’s lung cancer drug selumetinib has failed to hit its primary endpoint in a Phase II trial. The trial compared …

News

SHL receives Good Design Award for Molly Auto Injector

October 3, 2011
Manufacturing and Production auto injector, autoinjector, good design award, molly

SHL Group is honored to have recently received certification for the Good Design Award for its revolutionary auto injector, Molly. …

News
Press release

Jean-Pierre Garnier elected chairman of Actelion

October 3, 2011
Sales and Marketing appointment, sales and marketing

Jean-Pierre Garnier has been elected chairman of Swiss biopharmaceutical company Actelion. He has sat on the company’s board since May …

Appointment

Chinese API supplier under FDA scrutiny

October 3, 2011
Manufacturing and Production Sichuan Pharmaceutical, pharma manufacturing news

Chinese active ingredient manufacturer Sichuan Pharmaceutical has been sent a warning by the US FDA for failing to sort out …

News
Janssen's Psoriasis 360 campaign

Janssen repeats digital award success

September 30, 2011
Medical Communications PM Society Digital Awards

Janssen was once again the standout winner at last night’s PM Society’s Digital Media Awards. The pharma company beat its …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026